📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacological HDAC inhibition impairs pancreatic ß-cell function through an epigenome-wide reprogramming. (2023)

First Author: Oger F

Attributed to: Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.isci.2023.107231

PubMed Identifier: 37496675

Publication URI: http://europepmc.org/abstract/MED/37496675

Type: Journal Article/Review

Volume: 26

Parent Publication: iScience

Issue: 7

ISSN: 2589-0042